1 | ONCIPC8C ;Hines OIFO/GWB - Primary Intracranial/CNS Tumors PCE Study ;05/01/00
|
---|
2 | ;;2.11;ONCOLOGY;**26,32**;Mar 07, 1995
|
---|
3 | ;Print (continued)
|
---|
4 | W !?4,"CHEMOTHERAPY",!?4,"------------"
|
---|
5 | D P Q:EX=U
|
---|
6 | W !,"61. DATE CHEMOTHERAPY STARTED.....: ",$$GET1^DIQ(165.5,IE,53)
|
---|
7 | D P Q:EX=U
|
---|
8 | W !,"62. CHEMOTHERAPY..................: ",$$GET1^DIQ(165.5,IE,53.2)
|
---|
9 | D P Q:EX=U
|
---|
10 | W !
|
---|
11 | D P Q:EX=U
|
---|
12 | W !,"63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:"
|
---|
13 | D P Q:EX=U
|
---|
14 | W !," PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1346)
|
---|
15 | D P Q:EX=U
|
---|
16 | W !," CCNU.........................: ",$$GET1^DIQ(165.5,IE,1347)
|
---|
17 | D P Q:EX=U
|
---|
18 | W !," VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1348)
|
---|
19 | D P Q:EX=U
|
---|
20 | W !," HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1349)
|
---|
21 | D P Q:EX=U
|
---|
22 | W !," METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,376)
|
---|
23 | D P Q:EX=U
|
---|
24 | W !," CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,371)
|
---|
25 | D P Q:EX=U
|
---|
26 | W !," BCNU.........................: ",$$GET1^DIQ(165.5,IE,1350)
|
---|
27 | D P Q:EX=U
|
---|
28 | W !," BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1351)
|
---|
29 | D P Q:EX=U
|
---|
30 | W !," VP-16........................: ",$$GET1^DIQ(165.5,IE,1352)
|
---|
31 | D P Q:EX=U
|
---|
32 | W !," CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1353)
|
---|
33 | D P Q:EX=U
|
---|
34 | W !," TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1354)
|
---|
35 | D P Q:EX=U
|
---|
36 | W !," CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,372)
|
---|
37 | D P Q:EX=U
|
---|
38 | W !," CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1355)
|
---|
39 | D P Q:EX=U
|
---|
40 | W !," TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1356)
|
---|
41 | D P Q:EX=U
|
---|
42 | W !," INTERFERON...................: ",$$GET1^DIQ(165.5,IE,384)
|
---|
43 | D P Q:EX=U
|
---|
44 | W !," CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1357)
|
---|
45 | D P Q:EX=U
|
---|
46 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,380)
|
---|
47 | D P Q:EX=U
|
---|
48 | W !
|
---|
49 | D P Q:EX=U
|
---|
50 | W !,"64. CHEMOTHERAPEUTIC ROUTE........: ",$$GET1^DIQ(165.5,IE,1358)
|
---|
51 | D P Q:EX=U
|
---|
52 | W !
|
---|
53 | D P Q:EX=U
|
---|
54 | W !,"65. CHEMOTHERAPY COMPLICATIONS:"
|
---|
55 | D P Q:EX=U
|
---|
56 | W !," HEARING LOSS.................: ",$$GET1^DIQ(165.5,IE,1359)
|
---|
57 | D P Q:EX=U
|
---|
58 | W !," INFECTION....................: ",$$GET1^DIQ(165.5,IE,1360)
|
---|
59 | D P Q:EX=U
|
---|
60 | W !," NAUSEA AND VOMITING REQUIRING"
|
---|
61 | D P Q:EX=U
|
---|
62 | W !," CESSATION OF CHEMOTHERAPY...: ",$$GET1^DIQ(165.5,IE,1361)
|
---|
63 | D P Q:EX=U
|
---|
64 | W !," PERIPHERAL BLOOD COUNT DROP/"
|
---|
65 | D P Q:EX=U
|
---|
66 | W !," /BLEEDING/CESSATION OF CHEMO"
|
---|
67 | D P Q:EX=U
|
---|
68 | W !," AND/OR TRANSFUSION..........: ",$$GET1^DIQ(165.5,IE,1362)
|
---|
69 | D P Q:EX=U
|
---|
70 | W !," PERIPHERAL NEUROPATHY........: ",$$GET1^DIQ(165.5,IE,1363)
|
---|
71 | D P Q:EX=U
|
---|
72 | W !," RENAL FAILURE................: ",$$GET1^DIQ(165.5,IE,1364)
|
---|
73 | D P Q:EX=U
|
---|
74 | W !," PULMONARY TOXICITY...........: ",$$GET1^DIQ(165.5,IE,1365)
|
---|
75 | D P Q:EX=U
|
---|
76 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,1366)
|
---|
77 | D P Q:EX=U
|
---|
78 | W !
|
---|
79 | D P Q:EX=U
|
---|
80 | W !,"66. REASON FOR NO CHEMOTHERAPY....: ",$$GET1^DIQ(165.5,IE,76)
|
---|
81 | D P Q:EX=U
|
---|
82 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G OT
|
---|
83 | W !
|
---|
84 | D P Q:EX=U
|
---|
85 | OT W !?4,"OTHER THERAPY",!?4,"-------------"
|
---|
86 | D P Q:EX=U
|
---|
87 | W !,"67. DATE OTHER TREATMENT STARTED..: ",$$GET1^DIQ(165.5,IE,57)
|
---|
88 | D P Q:EX=U
|
---|
89 | W !,"68. OTHER TREATMENT...............: ",$$GET1^DIQ(165.5,IE,57.2)
|
---|
90 | D P Q:EX=U
|
---|
91 | W !,"69. KARNOFSKY'S RATING AT TIME OF"
|
---|
92 | D P Q:EX=U
|
---|
93 | W !," DISCHARGE/TRANSFER...........: ",$$GET1^DIQ(165.5,IE,1367)
|
---|
94 | D P Q:EX=U
|
---|
95 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G IV
|
---|
96 | D P Q:EX=U
|
---|
97 | IV S TABLE="RECURRENCE/PROGRESSION"
|
---|
98 | I IOST'?1"C".E W !
|
---|
99 | W !?4,TABLE,!?4,"----------------------"
|
---|
100 | D P Q:EX=U
|
---|
101 | W !,"70. DATE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,70)
|
---|
102 | D P Q:EX=U
|
---|
103 | W !,"71. TYPE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,1372)
|
---|
104 | D P Q:EX=U
|
---|
105 | W !,"72. DATE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1368)
|
---|
106 | D P Q:EX=U
|
---|
107 | W !,"73. TYPE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1369)
|
---|
108 | D P Q:EX=U
|
---|
109 | W !,"74. RECURRENCE/PROGRESSION"
|
---|
110 | D P Q:EX=U
|
---|
111 | W !," DOCUMENTATION................: ",$$GET1^DIQ(165.5,IE,1370)
|
---|
112 | D P Q:EX=U
|
---|
113 | W !,"75. KARNOFSKY'S RATING AT TIME OF"
|
---|
114 | D P Q:EX=U
|
---|
115 | W !," RECURRENCE/PROGRESSION.......: ",$$GET1^DIQ(165.5,IE,1371)
|
---|
116 | D P Q:EX=U
|
---|
117 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G V
|
---|
118 | W !
|
---|
119 | D P Q:EX=U
|
---|
120 | V S TABLE="SUBSEQUENT TREATMENT"
|
---|
121 | W !?4,TABLE,!?4,"--------------------"
|
---|
122 | D P Q:EX=U
|
---|
123 | S DSTRP=""
|
---|
124 | I $D(^ONCO(165.5,IE,4,0)) D
|
---|
125 | .S SCTIEN=$O(^ONCO(165.5,IE,4,0))
|
---|
126 | .Q:SCTIEN=""
|
---|
127 | .S DSTRP=$P(^ONCO(165.5,ONCONUM,4,SCTIEN,0),U,1)
|
---|
128 | .S Y=DSTRP D DATEOT^ONCOPCE S DSTRP=Y
|
---|
129 | W !,"76. DATE OF SUBSEQUENT TREATMENT"
|
---|
130 | D P Q:EX=U
|
---|
131 | W !," FOR RECURRENCE/PROGRESSION...: ",DSTRP
|
---|
132 | D P Q:EX=U
|
---|
133 | W !,"77. PROTOCOL PARTCIPATION"
|
---|
134 | D P Q:EX=U
|
---|
135 | W !," (SUBSEQUENT TREATMENT).......: ",$$GET1^DIQ(165.5,IE,1373)
|
---|
136 | D P Q:EX=U
|
---|
137 | W !,"78. TYPE OF SUBSEQUENT SURGICAL TX"
|
---|
138 | D P Q:EX=U
|
---|
139 | W !," FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1374)
|
---|
140 | D P Q:EX=U
|
---|
141 | W !,"79. TYPE OF SUBSEQUENT RADIATION"
|
---|
142 | D P Q:EX=U
|
---|
143 | W !," TX FOR RECURRENCE/PROGRESSION: ",$$GET1^DIQ(165.5,IE,1375)
|
---|
144 | D P Q:EX=U
|
---|
145 | W !
|
---|
146 | D P Q:EX=U
|
---|
147 | W !,"80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION:"
|
---|
148 | D P Q:EX=U
|
---|
149 | W !," PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1376)
|
---|
150 | D P Q:EX=U
|
---|
151 | W !," CCNU.........................: ",$$GET1^DIQ(165.5,IE,1377)
|
---|
152 | D P Q:EX=U
|
---|
153 | W !," VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1378)
|
---|
154 | D P Q:EX=U
|
---|
155 | W !," HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1379)
|
---|
156 | D P Q:EX=U
|
---|
157 | W !," METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,1380)
|
---|
158 | D P Q:EX=U
|
---|
159 | W !," CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,1381)
|
---|
160 | D P Q:EX=U
|
---|
161 | W !," BCNU.........................: ",$$GET1^DIQ(165.5,IE,1382)
|
---|
162 | D P Q:EX=U
|
---|
163 | W !," BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1383)
|
---|
164 | D P Q:EX=U
|
---|
165 | W !," VP-16........................: ",$$GET1^DIQ(165.5,IE,1384)
|
---|
166 | D P Q:EX=U
|
---|
167 | W !," CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1385)
|
---|
168 | D P Q:EX=U
|
---|
169 | W !," TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1386)
|
---|
170 | D P Q:EX=U
|
---|
171 | W !," CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,1387)
|
---|
172 | D P Q:EX=U
|
---|
173 | W !," CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1388)
|
---|
174 | D P Q:EX=U
|
---|
175 | W !," TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1389)
|
---|
176 | D P Q:EX=U
|
---|
177 | W !," INTERFERON...................: ",$$GET1^DIQ(165.5,IE,1390)
|
---|
178 | D P Q:EX=U
|
---|
179 | W !," CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1391)
|
---|
180 | D P Q:EX=U
|
---|
181 | W !," OTHER........................: ",$$GET1^DIQ(165.5,IE,1392)
|
---|
182 | D P Q:EX=U
|
---|
183 | W !
|
---|
184 | D P Q:EX=U
|
---|
185 | W !,"81. OTHER TYPE OF SUBSEQUENT TX"
|
---|
186 | D P Q:EX=U
|
---|
187 | W !," FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1393)
|
---|
188 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y D HEAD^ONCIPC0 G VI
|
---|
189 | W !
|
---|
190 | D P Q:EX=U
|
---|
191 | VI S TABLE="STATUS AT LAST CONTACT"
|
---|
192 | W !?4,TABLE,!?4,"----------------------"
|
---|
193 | D P Q:EX=U
|
---|
194 | S DLC="" I $D(^ONCO(160,ONCOPA,"F","B")) S DLC=$O(^ONCO(160,ONCOPA,"F","B",""),-1)
|
---|
195 | I DLC'="" S Y=DLC D DATEOT^ONCOPCE S DLC=Y
|
---|
196 | W !,"82. DATE OF LAST CONTACT OR DEATH.: ",DLC
|
---|
197 | D P Q:EX=U
|
---|
198 | W !,"83. VITAL STATUS..................: ",$$GET1^DIQ(160,ONCOPA,15)
|
---|
199 | D P Q:EX=U
|
---|
200 | S CS="" I $D(^ONCO(165.5,IE,"TS","AA")) D
|
---|
201 | .S CSDAT=$O(^ONCO(165.5,IE,"TS","AA",""))
|
---|
202 | .S CSI=$O(^ONCO(165.5,IE,"TS","AA",CSDAT,""))
|
---|
203 | .S CSPNT=$P(^ONCO(165.5,IE,"TS",CSI,0),U,2)
|
---|
204 | .S CS=$P(^ONCO(164.42,CSPNT,0),U,1)
|
---|
205 | W !,"84. CANCER STATUS.................: ",CS
|
---|
206 | I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR
|
---|
207 | Q
|
---|
208 | P ;Print
|
---|
209 | I ($Y'<(LIN-1)) D Q:EX=U
|
---|
210 | .I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR I 'Y S EX=U Q
|
---|
211 | .D HEAD^ONCIPC0 Q
|
---|
212 | Q
|
---|